Laura Cameron

UF Health first to place kidney-assist device that might help patients with congestive heart failure

University of Florida Health researchers recently became the first to temporarily implant a new device in a patient with congestive heart failure, a procedure that one day could help physicians manage this potentially deadly condition. Physicians in the UF College of Medicine’s department of urology and division of cardiovascular medicine performed the first-in-human use of …

UF Health first to place kidney-assist device that might help patients with congestive heart failure Read More »

3ive Labs Names Dr. Lance Black as Senior Medical Director

Roswell, GA, March 26, 2021–3ive Labs (pronounced \ˈthrīv\), a medical device product development organization focused on treating kidney disease, today announces the appointment of Lance Black, MD, MBID as Senior Medical Director.  Dr. Black brings 20 years of experience as a clinician, engineer and innovator.   In this new role, Dr. Black will lead the development of …

3ive Labs Names Dr. Lance Black as Senior Medical Director Read More »

Strataca Systems®, Ltd. To Present New Data Demonstrating Improved Kidney Function Associated with JuxtaFlow® Renal Negative Pressure Treatment in Animal Models With and Without Congestive Heart Failure

New Poster Offered at the American Society of Nephrology’s Kidney Week Virtual Conference October 22 – October 25, 2020 Demonstrates Improved Urine Output, Sodium Excretion, and Glomerular Filtration Rate Associated with JuxtaFlow Treatment   Floriana, Malta — October 22, 2020 – (GLOBE NEWSWIRE) – Strataca Systems, Ltd., a clinical stage company developing medical devices designed …

Strataca Systems®, Ltd. To Present New Data Demonstrating Improved Kidney Function Associated with JuxtaFlow® Renal Negative Pressure Treatment in Animal Models With and Without Congestive Heart Failure Read More »

Strataca Systems®, Ltd. Presents Data Demonstrating Improved Kidney Function Associated with JuxtaFlow® Renal Negative Pressure Treatment in Animal Models With and Without Congestive Heart Failure, Paving the Way For Human Clinical Trials

New Data Presented as Part of Moderated Poster Session at the Heart Failure Society of America Virtual Conference held September 30 – October 3, 2020 Roswell, Ga. – October 1, 2020 – (GLOBE NEWSWIRE) – Strataca Systems, Ltd., a clinical stage company developing medical devices designed to improve kidney function in patients with congestion and …

Strataca Systems®, Ltd. Presents Data Demonstrating Improved Kidney Function Associated with JuxtaFlow® Renal Negative Pressure Treatment in Animal Models With and Without Congestive Heart Failure, Paving the Way For Human Clinical Trials Read More »

Scroll to Top
SENIOR MEDICAL DIRECTOR

Lance Black, MD, MBID

Lance is the team’s senior medical director. As an engineer, physician, and innovator, he speaks a multitude of technical languages and serves as an intermediary and catalyst in the ever-demanding path of medical device development. He obtained his MD from LSU Health Sciences Center of New Orleans, his BS in Biological Engineering from LSU respectively; and his Masters of Biomedical Innovation and Development from the Georgia Institute of Technology. Dr. Black served in the United States Air Force as a Family and Flight Medicine physician where he deployed twice; leading the rapid response team for F-22 pilots in Okinawa, Japan, and as Chief of the Medical Staff at Manas Transit Air Base in Kyrgyzstan. Following his military commitment, Dr. Black worked as the Medical Affairs Manager for the medtech development firm GCMI, where he participated in the build-out and testing of over 25 medical devices with contribution on more than 30 patents. Most recently as Associate Director of Texas Medical Center Innovation Institute, he focused on building and launching novel medical device and digital health companies. During his tenure at TMC Innovation, Lance had the opportunity to review and screen over 2000 healthcare startups for entry into the well-known accelerator, TMCx; advised over 100 medical device and digital health companies who have collectively raised more than $2.5B; and aided in the launch of 10 healthcare startups as advisor to TMC Biodesign who to date have raised >$30M. Dr. Black is singularly dedicated in supporting the development of novel medical technologies that bring value to patients.